☰

Kyle J. Savage, Ph.D. - Publications

Affiliations: 
2012 Kinesiology University of Maryland, College Park, College Park, MD 
Area:
Recreation, Physiological Psychology
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

32 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Kansara R, Connors JM, Savage KJ, Gerrie AS, Scott DW, Slack GW, Gascoyne RD, Sehn LH, Villa D. Maintenance rituximab following induction R-CHOP chemotherapy in patients with composite or discordant, indolent and aggressive, B-cell non-Hodgkin lymphomas. Haematologica. PMID 27479818 DOI: 10.3324/haematol.2016.144550  0.305
2016 Schmitz N, Zeynalova S, Nickelsen M, Kansara R, Villa D, Sehn LH, Glass B, Scott DW, Gascoyne RD, Connors JM, Ziepert M, Pfreundschuh M, Loeffler M, Savage KJ. CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 27382100 DOI: 10.1200/JCO.2015.65.6520  0.309
2016 Moccia AA, Hitz F, Hoskins P, Klasa R, Power MM, Savage KJ, Shenkier T, Shepherd JD, Slack GW, Song KW, Gascoyne RD, Connors JM, Sehn LH. Gemcitabine, dexamethasone, and cisplatin (GDP) is an effective and well-tolerated salvage therapy for relapsed/refractory diffuse large B-cell lymphoma and Hodgkin lymphoma. Leukemia & Lymphoma. 1-9. PMID 27347845 DOI: 10.1080/10428194.2016.1193852  0.353
2015 Advani RH, Ansell SM, Lechowicz MJ, Beaven AW, Loberiza F, Carson KR, Evens AM, Foss F, Horwitz S, Pro B, Pinter-Brown LC, Smith SM, Shustov AR, Savage KJ, M Vose J. A phase II study of cyclophosphamide, etoposide, vincristine and prednisone (CEOP) Alternating with Pralatrexate (P) as front line therapy for patients with peripheral T-cell lymphoma (PTCL): final results from the T- cell consortium trial. British Journal of Haematology. PMID 26627450 DOI: 10.1111/Bjh.13855  0.34
2015 Hitz F, Connors JM, Gascoyne RD, Hoskins P, Moccia A, Savage KJ, Sehn LH, Shenkier T, Villa D, Klasa R. Outcome of patients with primary refractory diffuse large B cell lymphoma after R-CHOP treatment. Annals of Hematology. 94: 1839-43. PMID 26246466 DOI: 10.1007/s00277-015-2467-z  0.303
2015 Hapgood G, Savage KJ. The biology and management of systemic anaplastic large cell lymphoma. Blood. 126: 17-25. PMID 25869285 DOI: 10.1182/blood-2014-10-567461  0.326
2015 Sun H, Savage KJ, Karsan A, Slack GW, Gascoyne RD, Toze CL, Sehn LH, Abou Mourad Y, Barnett MJ, Broady RC, Connors JM, Forrest DL, Gerrie AS, Hogge DE, Narayanan S, et al. Outcome of Patients With Non-Hodgkin Lymphomas With Concurrent MYC and BCL2 Rearrangements Treated With CODOX-M/IVAC With Rituximab Followed by Hematopoietic Stem Cell Transplantation. Clinical Lymphoma, Myeloma & Leukemia. 15: 341-8. PMID 25656914 DOI: 10.1016/J.Clml.2014.12.015  0.304
2014 Villa D, George A, Seymour JF, Toze CL, Crump M, Lee C, Buckstein R, Stewart DA, MacDonald D, Foley R, Xenocostas A, Sabloff M, Chua N, Couture F, Larouche JF, ... ... Savage KJ, et al. Favorable outcomes from allogeneic and autologous stem cell transplantation for patients with transformed nonfollicular indolent lymphoma. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 20: 1813-8. PMID 25042735 DOI: 10.1016/j.bbmt.2014.07.015  0.306
2014 Xing KH, Connors JM, Lai A, Al-Mansour M, Sehn LH, Villa D, Klasa R, Shenkier T, Gascoyne RD, Skinnider B, Savage KJ. Advanced-stage nodular lymphocyte predominant Hodgkin lymphoma compared with classical Hodgkin lymphoma: a matched pair outcome analysis. Blood. 123: 3567-73. PMID 24713929 DOI: 10.1182/blood-2013-12-541078  0.307
2013 Mak V, Hamm J, Chhanabhai M, Shenkier T, Klasa R, Sehn LH, Villa D, Gascoyne RD, Connors JM, Savage KJ. Survival of patients with peripheral T-cell lymphoma after first relapse or progression: spectrum of disease and rare long-term survivors. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 1970-6. PMID 23610113 DOI: 10.1200/JCO.2012.44.7524  0.366
2013 Ferreri AJ, Govi S, Pileri SA, Savage KJ. Anaplastic large cell lymphoma, ALK-negative. Critical Reviews in Oncology/Hematology. 85: 206-15. PMID 22789917 DOI: 10.1016/j.critrevonc.2012.06.004  0.357
2012 Johnson NA, Slack GW, Savage KJ, Connors JM, Ben-Neriah S, Rogic S, Scott DW, Tan KL, Steidl C, Sehn LH, Chan WC, Iqbal J, Meyer PN, Lenz G, Wright G, et al. Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 3452-9. PMID 22851565 DOI: 10.1200/Jco.2011.41.0985  0.326
2012 Mitrovic Z, Perry AM, Suzumiya J, Armitage JO, Au WY, Coiffier B, Holte H, Jaffe ES, Monserrat E, Rajan SK, Savage KJ, Tobinai K, Vose JM, Weisenburger DD. The prognostic significance of lymphopenia in peripheral T-cell and natural killer/T-cell lymphomas: a study of 826 cases from the International Peripheral T-cell Lymphoma Project. American Journal of Hematology. 87: 790-4. PMID 22488678 DOI: 10.1002/ajh.23205  0.344
2012 Ferreri AJ, Govi S, Pileri SA, Savage KJ. Anaplastic large cell lymphoma, ALK-positive. Critical Reviews in Oncology/Hematology. 83: 293-302. PMID 22440390 DOI: 10.1016/j.critrevonc.2012.02.005  0.391
2011 Savage KJ. Therapies for peripheral T-cell lymphomas. Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program. 2011: 515-24. PMID 22160083 DOI: 10.1182/asheducation-2011.1.515  0.327
2011 Delabie J, Holte H, Vose JM, Ullrich F, Jaffe ES, Savage KJ, Connors JM, Rimsza L, Harris NL, Müller-Hermelink K, Rüdiger T, Coiffier B, Gascoyne RD, Berger F, Tobinai K, et al. Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project. Blood. 118: 148-55. PMID 21566094 DOI: 10.1182/blood-2011-02-335216  0.342
2011 Weisenburger DD, Savage KJ, Harris NL, Gascoyne RD, Jaffe ES, MacLennan KA, Rüdiger T, Pileri S, Nakamura S, Nathwani B, Campo E, Berger F, Coiffier B, Kim WS, Holte H, et al. Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project. Blood. 117: 3402-8. PMID 21270441 DOI: 10.1182/blood-2010-09-310342  0.335
2011 O'Connor OA, Pro B, Pinter-Brown L, Bartlett N, Popplewell L, Coiffier B, Lechowicz MJ, Savage KJ, Shustov AR, Gisselbrecht C, Jacobsen E, Zinzani PL, Furman R, Goy A, Haioun C, et al. Pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma: results from the pivotal PROPEL study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 1182-9. PMID 21245435 DOI: 10.1200/JCO.2010.29.9024  0.322
2010 Villa D, Connors JM, Shenkier TN, Gascoyne RD, Sehn LH, Savage KJ. Incidence and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: the impact of the addition of rituximab to CHOP chemotherapy. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 21: 1046-52. PMID 19861575 DOI: 10.1093/annonc/mdp432  0.327
2009 Savage KJ, Johnson NA, Ben-Neriah S, Connors JM, Sehn LH, Farinha P, Horsman DE, Gascoyne RD. MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy. Blood. 114: 3533-7. PMID 19704118 DOI: 10.1182/blood-2009-05-220095  0.334
2009 Johnson NA, Savage KJ, Ludkovski O, Ben-Neriah S, Woods R, Steidl C, Dyer MJ, Siebert R, Kuruvilla J, Klasa R, Connors JM, Gascoyne RD, Horsman DE. Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival. Blood. 114: 2273-9. PMID 19597184 DOI: 10.1182/blood-2009-03-212191  0.36
2008 O'Leary HM, Savage KJ. Novel therapies in peripheral T-cell lymphomas. Current Hematologic Malignancy Reports. 3: 213-20. PMID 20425468 DOI: 10.1007/s11899-008-0030-x  0.324
2008 Savage KJ. Prognosis and primary therapy in peripheral T-cell lymphomas. Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program. 280-8. PMID 19074097 DOI: 10.1182/asheducation-2008.1.280  0.355
2008 O'Leary HM, Savage KJ. Novel therapies in peripheral T-cell lymphomas. Current Oncology Reports. 10: 404-11. PMID 18706268  0.324
2008 Savage KJ, Harris NL, Vose JM, Ullrich F, Jaffe ES, Connors JM, Rimsza L, Pileri SA, Chhanabhai M, Gascoyne RD, Armitage JO, Weisenburger DD. ALK - anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK + ALCL and peripheral T-cell lymphoma, not otherwise specified: Report from the International Peripheral T-Cell Lymphoma Project Blood. 111: 5496-5504. PMID 18385450 DOI: 10.1182/blood-2008-01-134270  0.356
2007 Savage KJ. Peripheral T-cell lymphomas. Blood Reviews. 21: 201-16. PMID 17512649 DOI: 10.1016/j.blre.2007.03.001  0.321
2006 Savage KJ. Primary mediastinal large B-cell lymphoma. The Oncologist. 11: 488-95. PMID 16720849 DOI: 10.1634/theoncologist.11-5-488  0.333
2006 Savage KJ, Al-Rajhi N, Voss N, Paltiel C, Klasa R, Gascoyne RD, Connors JM. Favorable outcome of primary mediastinal large B-cell lymphoma in a single institution: the British Columbia experience. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 17: 123-30. PMID 16236753 DOI: 10.1093/annonc/mdj030  0.328
2005 Savage KJ. Aggressive peripheral T-cell lymphomas (specified and unspecified types). Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program. 267-77. PMID 16304391 DOI: 10.1182/asheducation-2005.1.267  0.336
2005 Laskin JJ, Savage KJ, Voss N, Gascoyne RD, Connors JM. Primary paranasal sinus lymphoma: Natural history and improved outcome with central nervous system chemoprophylaxis Leukemia and Lymphoma. 46: 1721-1727. PMID 16263574 DOI: 10.1080/17402520500182345  0.359
2005 Rodig SJ, Savage KJ, Nguyen V, Pinkus GS, Shipp MA, Aster JC, Kutok JL. TRAF1 expression and c-Rel activation are useful adjuncts in distinguishing classical Hodgkin lymphoma from a subset of morphologically or immunophenotypically similar lymphomas. The American Journal of Surgical Pathology. 29: 196-203. PMID 15644776  0.309
2004 Savage KJ, Chhanabhai M, Gascoyne RD, Connors JM. Characterization of peripheral T-cell lymphomas in a single North American institution by the WHO classification Annals of Oncology. 15: 1467-1475. PMID 15367405 DOI: 10.1093/annonc/mdh392  0.362
Show low-probability matches.